Karuna Therapeutics
Clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions.
Launch date
Employees
Market cap
$12.6b
Enterprise valuation
$11.4b (Public information from Mar 2024)
Share price
$329.82999 KRTX
Boston Massachusetts (HQ)
Authorizing premium user...